Takeda Joins WIPO Re:Search To Accelerate R&D Of New Drugs For Neglected Tropical Diseases, Malaria And TB

OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced its participation in WIPO Re:Search, a consortium to accelerate research and development (R&D) of new drugs, vaccines, and diagnostics for neglected tropical diseases, malaria and tuberculosis (TB). WIPO Re:Search’s aim is to advance product development through greater collaboration while making concrete contributions to strengthen the foundations of healthcare in developing countries.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC